Pancreatic Cancer Research

Journal articleInt J Cancer2019

Metformin and pancreatic cancer survival: Real effect or immortal time bias?

Journal
Int J Cancer
Published
25 March 2019
Citations
21
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

High heterogeneity has been reported among cohort studies investigating the association between metformin and pancreatic cancer survival. Immortal time bias may be one importance source of heterogeneity, as it is widely present in previous cohort studies and may severely impair the validity. … Excerpt only: this text is the publisher’s. Read it in full at the source.